The Medicinal Properties of Wild Honey: Manuka, Tualang, and Sidr Honey in Cancer Treatment and Other Diseases

Liste des GroupesRevenir à sc polish 
Sujet : The Medicinal Properties of Wild Honey: Manuka, Tualang, and Sidr Honey in Cancer Treatment and Other Diseases
De : manta103g (at) *nospam* gmail.com (darius)
Groupes : soc.culture.polish
Date : 24. Feb 2025, 16:28:44
Autres entêtes
Organisation : novaBBS
Message-ID : <a461d9e855a179562c05a9cd861e69b2@www.novabbs.com>
User-Agent : Rocksolid Light
The Medicinal Properties of Wild Honey: Manuka, Tualang, and Sidr Honey
in Cancer Treatment and Other Diseases
Abstract
Wild honey has been used in traditional medicine for centuries, and
recent scientific studies suggest its potential in treating various
diseases, including cancer. This paper explores the bioactive compounds
of Manuka, Tualang, and Sidr honey and their therapeutic effects,
particularly their anticancer properties. We analyze their mechanisms of
action, antimicrobial, anti-inflammatory, and immune-modulating effects,
as well as current clinical studies supporting their use in medical
applications.
1. Introduction
Honey has long been recognized for its medicinal properties, with
different types of wild honey exhibiting unique bioactive
characteristics. Among them, Manuka honey (New Zealand and Australia),
Tualang honey (Malaysia), and Sidr honey (Middle East) have been widely
studied for their potent antimicrobial and antioxidant activities. This
paper aims to explore their potential in cancer treatment and other
health conditions.
2. Composition of Wild Honey
Wild honey contains a complex mixture of bioactive compounds, including:
Flavonoids and phenolic acids (quercetin, gallic acid, chrysin) with
antioxidant properties.
Enzymes (glucose oxidase) producing hydrogen peroxide, a key
antimicrobial agent.
Methylglyoxal (MGO), particularly in Manuka honey, which has been linked
to potent antibacterial and anticancer properties.
High sugar content and low pH, creating an environment that inhibits
bacterial growth.
3. Anticancer Properties of Wild Honey
3.1 Manuka Honey
Manuka honey, rich in methylglyoxal (MGO) and phenolic compounds, has
shown promising anticancer effects in studies. It induces apoptosis
(programmed cell death) in various cancer cell lines, including breast,
colorectal, and melanoma cells. It also inhibits tumor angiogenesis and
metastasis.
3.2 Tualang Honey
Tualang honey, derived from the Tualang tree (Koompassia excelsa),
contains high levels of flavonoids, which exhibit strong antioxidant and
cytotoxic effects on cancer cells. Research suggests that Tualang honey
can suppress tumor growth and enhance the efficacy of chemotherapy
agents.
3.3 Sidr Honey
Sidr honey, produced from the Ziziphus spina-christi tree, possesses
potent anti-inflammatory, antioxidant, and antimicrobial properties.
Studies indicate its potential to reduce oxidative stress and
inflammatory markers, which are critical in cancer progression.
4. Mechanisms of Action
Induction of Apoptosis: Activation of intrinsic and extrinsic pathways
leading to programmed cancer cell death.
Reduction of Oxidative Stress: Neutralization of reactive oxygen species
(ROS), preventing DNA damage.
Anti-Angiogenic Properties: Inhibition of blood vessel formation that
supports tumor growth.
Enhancement of Immune Response: Modulation of immune cells, including
macrophages and T-cells.
5. Therapeutic Benefits Beyond Cancer
Antimicrobial Effects: Effective against antibiotic-resistant bacteria
such as MRSA.
Wound Healing: Accelerates tissue regeneration and reduces scarring.
Anti-Inflammatory Properties: Beneficial in conditions like arthritis
and inflammatory bowel disease (IBD).
Diabetes Management: Lowers glycemic response and improves insulin
sensitivity.
6. Clinical Studies and Future Directions
Several in vitro and in vivo studies support the medicinal properties of
wild honey, but more randomized clinical trials (RCTs) are needed to
establish its efficacy in cancer treatment. Future research should focus
on:
Standardizing honey compositions for therapeutic use.
Exploring synergistic effects with conventional treatments.
Investigating bioavailability and dosage optimization.
7. Conclusion
Wild honey, particularly Manuka, Tualang, and Sidr honey, exhibits
significant potential in cancer treatment and other diseases due to its
bioactive compounds. While promising results have been observed in
laboratory studies, further clinical trials are required to validate
these findings and explore their full therapeutic potential.
References
Ahmed, S., Othman, N. H. (2013). "Honey as a potential natural
anticancer agent: A review of its mechanisms." Evidence-Based
Complementary and Alternative Medicine.
Erejuwa, O. O., Sulaiman, S. A., Wahab, M. S. (2014). "Honey: A novel
antioxidant." Molecules, 19(5), 5048–5068.
Jaganathan, S. K., Mandal, M. (2009). "Antiproliferative effects of
honey and its polyphenols." Journal of Biomedicine and Biotechnology.
Almasaudi, S. B. (2021). "Manuka honey: An emerging natural
antimicrobial agent." Future Microbiology.
Kek, S. P., Chin, N. L., Yusof, Y. A., Tan, S. W. (2014). "Tualang honey
and its potential therapeutic effects." Frontiers in Pharmacology.
--

Date Sujet#  Auteur
24 Feb 25 * The Medicinal Properties of Wild Honey: Manuka, Tualang, and Sidr Honey in Cancer Treatment and Other Diseases2darius
25 Feb 25 `- Re: The Medicinal Properties of Wild Honey: Manuka, Tualang, and Sidr Honey in Cancer Treatment and Other Diseases1andal

Haut de la page

Les messages affichés proviennent d'usenet.

NewsPortal